Jeremy T Larsen Selected Research

Jeremy T Larsen Research Topics

8	Multiple Myeloma 10/2022 - 09/2011
2	Amyloidosis 01/2022 - 01/2018
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 08/2013
2	Immunoglobulin Light-chain Amyloidosis 01/2022 - 01/2021
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 11/2020
1	Toxic Optic Neuropathy 10/2022
1	Mast-Cell Leukemia (Leukemia, Mast Cell) 01/2022
1	Systemic Mastocytosis 01/2022
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2021
1	Inflammation (Inflammations) 01/2019
1	Hypoalbuminemia 01/2019
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2017
1	Neoplasms (Cancer) 04/2016

2	Bortezomib (Velcade)FDA Link 01/2022 - 01/2018
1	Immunoconjugates (Immunoconjugate)IBA 10/2022
1	B-Cell Maturation AntigenIBA 10/2022
1	belantamab mafodotinIBA 10/2022
1	Proteasome InhibitorsIBA 01/2022
1	midostaurinIBA 01/2022
1	ixazomibIBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2021
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2021
1	Pharmaceutical PreparationsIBA 11/2020
1	CytokinesIBA 01/2019
1	Bendamustine Hydrochloride FDA Link 08/2017
1	Rituximab (Mabthera)FDA Link 08/2017
1	MK 2206IBA 08/2017
1	Lenalidomide (CC 5013)FDA Link 04/2016
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 08/2013
1	thymoglobulin FDA Link 08/2013
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 08/2013
1	Cladribine FDA LinkGeneric 08/2013

9	Therapeutics 01/2022 - 09/2011
1	Drug Tapering 10/2022
1	Precision Medicine 11/2020
1	Hematopoietic Stem Cell Transplantation 01/2019
1	Stem Cell Transplantation 01/2018